1. Super Micro faces potential delisting if Nasdaq's plan is not approved; 2. Despite a 32% growth forecast, risks include competition and potential restatements; 3. Products are becoming more commoditized with lower gross margins than in the AI space.
Related Articles
- Hims & Hers Health: Explosive Growth Potential Ahead9 months ago
- Netflix Earnings: Why $1000 Is A Bargain For Investors9 months ago
- Grab Holdings Is Cheaper Than It Looks25 days ago
- Driven To Perform: Top 3 Auto Stocksabout 1 month ago
- Broadcom: 4 Reasons Why It Is Still A Buyabout 1 month ago
- Shopify: Pay The Right Priceabout 1 month ago
- UnitedHealth: I Was Bullish Before Buffett, But Even More So Nowabout 1 month ago
- September Dogs Of The Dow Unleash One Ideal 'Safer' DiviDogabout 2 months ago
- 2 Stocks I Expect To Likely Double Before The Market Doesabout 2 months ago
- Hims & Hers Health: Still Undervaluedabout 2 months ago